Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGN2P36 (high mobility group nucleosomal binding domain 2 pseudogene 36) is a human pseudogene located on chromosome 11 (11:13610363-13610771)[5][10]. As a pseudogene, it is a non-functional genomic DNA sequence that resembles the high mobility group nucleosomal binding domain 2 (HMGN2) gene. Pseudogenes like HMGN2P36 are typically generated by duplication or retrotransposition events involving functional genes, followed by the accumulation of mutations that prevent the formation of a functional protein[2][8][7]. There is currently no evidence for a protein product or conventional gene function for HMGN2P36, nor any established role in disease or therapy. HMGN2P36 is a pseudogene, does not encode a functional protein, and is not a therapeutic target. No known drugs, biomarkers, safety concerns, or disease roles exist for this entry. The designation "target" is inappropriate for HMGN2P36 in the context of molecular pharmacology or drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 36 (HMGN2P36).